BPA
CNMD icon

Beacon Pointe Advisors’s CONMED CNMD Stock Holding History

Beacon Pointe Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,986
Closed -$200K – 1337
2023
Q3 		$200K Buy
1,986
+437
+28% +$50.2K ﹤0.01% 1237
2023
Q2 		$210K Buy
+1,549
New +$189K ﹤0.01% 996
2022
Q2 		– Sell
-1,543
Closed -$229K – 1073
2022
Q1 		$229K Buy
+1,543
New +$215K ﹤0.01% 1078

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Beacon Pointe Advisors's CNMD Position: Q4 2023 in Review

Beacon Pointe Advisors sold out of CONMED (CNMD) in Q4 2023, closing a stake of 1,986 shares — an estimated $200K sold.

Beacon Pointe Advisors first reported a position in CNMD in Q1 2022 and held it in 3 quarters. The position peaked at $229K in Q1 2022. 306 funds tracked by Wall St. Rank hold CNMD as of Q4 2023.

  • Beacon Pointe Advisors reported no remaining CONMED position as of Q4 2023 after selling out during the quarter.
  • Beacon Pointe Advisors sold 1,986 CONMED shares in Q4 2023, an estimated $200K.
  • Beacon Pointe Advisors first reported a position in CONMED in Q1 2022 and held it in 3 quarters.
  • Beacon Pointe Advisors's CONMED position peaked at $229K in Q1 2022.
  • 306 funds tracked by Wall St. Rank held CONMED as of Q4 2023.

Based on Beacon Pointe Advisors's 13F filing for Q4 2023, filed 8 Feb 2024.